Abstract
Authors have studied the antitumor efficacy of contact radiation therapy (CRT) in combination with a chlorin-based photosensitizer (PS) in an experiment on laboratory animals with transplanted tumors. The experimental study was performed in 50 white outbred rats weighing 250±50 g. Subcutaneously transplanted Pliss lymphosarcoma (PLS) and alveolar liver cancer RS1 (RS1) were used as tumor models. Chlorinbased PS photolon (RUE «Belmedpreparaty», Republic Belarus) was injected intravenously at a dose of 2.5 mg/kg. The radiation sessions were carried out 2.5–4 hours (depending on the tumor model) after the administration of the PS using the device «microSelectron HDR V3 Digital» («Nucletron», Netherlands) with a 192-Ir radiation source in single focal doses 5 and 10 Gy. All laboratory animals (for PLS and RS1) were subdivided into 5 groups of 5 animals each: intact control, CRT 5 Gy, CRT 10 Gy, PS + CRT 5 Gy, PS + CRT 10 Gy. For the PLS tumor model – on the 14th day from the beginning of the experiment Vav. in groups were 26.31±5.81; 22.45±6.97; 18.99±4.86; 10.75±5.18 and 28.06±2.85 cm3, respectively (p˂0.05). The coefficients of tumor growth inhibition in the experimental groups were 14.67%, 27.82%, 59.14% and 6.65%, respectively. The frequency of complete tumor regressions 60 days after the start of the experiment was 0%, 20%, 20%, 60%, and 20%, respectively. On RS1 tumor model – on the 14th day from the beginning of the experiment Vav. in groups were 4.48±1.03; 0.80±0.21; 0.29±0.09; 0.19±0.07 and 0.32±0.08 cm3, respectively (p=0.009). The coefficients of tumor growth inhibition in the experimental groups were 82.14%, 93.53%, 95.76% and 92.86%, respectively. The frequency of complete tumor regressions 60 days after the start of the experiment was 0%, 0%, 20%, 0%, and 0%, respectively. Systemic administration of chlorin-based PS before the CRT session increases the antitumor efficacy of radiation therapy in animals with transplantable tumors of different histological structure and growth patterns. The data obtained indicate that further studies of the radiosensitizing properties of PS are promising.
Highlights
Authors have studied the antitumor efficacy of contact radiation therapy (CRT) in combination with a chlorin-based photosensitizer (PS) in an experiment on laboratory animals with transplanted tumors
The data obtained indicate that further studies of the radiosensitizing properties of PS are promising
Schaffer M. et al Feasibility of photofrin II as a radiosensitizing agent in solid tumors – preliminary results // Onkologie. – 2006. – Vol 29. – P. 514–519
Summary
Суслова Противоопухолевая эффективность контактной лучевой терапии в комбинации с фотосенсибилизатором хлоринового ряда в эксперименте. Авторами изучена противоопухолевая эффективность контактной лучевой терапии (КЛТ) в комбинации с фотосенсибилизатором (ФС) хлоринового ряда в эксперименте на лабораторных животных с перевивными опухолями. На модели ЛСП на 14–е сутки от начала воздействий средний объем опухоли (Vср) в группах составил 26,31±5,81; 22,45±6,97; 18,99±4,86; 10,75±5,18 и 28,06±2,85 см, соответственно (р0,05). Коэффициент торможения роста опухоли (ТРО) в опытных группах составил 14,67%; 27,82%; 59,14% и - 6,65%, соответственно. Результаты исследования показали, что введение ФС хлоринового ряда перед сеансом КЛТ увеличивает противоопухолевую эффективность лучевой терапии у животных с различными по гистологической структуре и характеру роста перевивными опухолями. Для цитирования: Церковский Д.А., Протопович Е.Л., Козловский Д.И., Суслова В.А. Противоопухолевая эффективность контактной лучевой терапии в комбинации с фотосенсибилизатором хлоринового ряда в эксперименте // Biomedical Photonics.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.